{
  "id": 8754,
  "url": "https://doi.org/10.3389/fchem.2020.00343",
  "title": "Structure-Based Virtual Screening: From Classical to Artificial Intelligence",
  "summary": "The drug development process is a major challenge in the pharmaceutical industry since it takes a substantial amount of time and money to move through all the phases of developing of a new drug. One extensively used method to minimize the cost and time for the drug development process is computer-aided drug design (CADD). CADD allows better focusing on experiments, which can reduce the time and cost involved in researching new drugs. In this context, structure-based virtual screening (SBVS) is r",
  "authors": "Eduardo Habib Bechelane Maia, Letícia C. Assis, Tiago Alves de Oliveira, Alisson Marques da Silva, Alex Gutterres Taranto",
  "category": "research",
  "topics": "healthcare,biotech",
  "orgs": null,
  "regions": null,
  "published_at": "2020-04-28T00:00:00.000Z",
  "fetched_at": "2026-07-14T16:33:43.490Z",
  "source_slug": "openalex",
  "source_name": "OpenAlex",
  "source_homepage": "https://openalex.org",
  "ethics_ai_record_url": "https://ethics.ai/record/8754",
  "original_url": "https://doi.org/10.3389/fchem.2020.00343",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}